Delta Still Dominates Say Experts Urging Third Jab
Umer Jamshaid Published December 04, 2021 | 01:46 PM
No one knows how effective vaccines will be in stopping people catching the newly discovered and fast-spreading Omicron variant of Covid-19 or how well they will protect against severe illness
Paris, Dec 4 (UrduPoint / Pakistan Point News - 4th Dec, 2021 ) :No one knows how effective vaccines will be in stopping people catching the newly discovered and fast-spreading Omicron variant of Covid-19 or how well they will protect against severe illness.
Lab tests are under way to determine vaccine efficacy against Omicron with results expected within weeks.
In the meantime the Delta variant remains dominant and experts, governments and vaccine makers are urging people to take advantage of booster jabs where they are available.
Delta has proved able to evade vaccine defences against transmission better than the Alpha, Beta and Gamma Covid variants.
But jabs have remained highly effective at preventing severe illness from Delta, lowering the risk of overwhelming hospital resources.
With Delta still dominant in Europe, some countries are trying to accelerate their third jab campaigns.
UK prime minister Boris Johnson set a goal of offering a booster to all adults by the end of January and decreasing the waiting period between second and third jabs from six to three months.
In the US, Pfizer is seeking authorisation for its jab to be given as a booster to 16- and 17-year-olds.
"It would be a serious mistake to slow down now," said Alain Fischer, who coordinates France's pandemic vaccine strategy.
"Our message is: Don't freak out, the plan remains the same: Speed up the administration of a third booster shot," BioNTech co-founder Ugur Sahin said on Tuesday.
But Moderna chief Stephane Bancel told the Financial Times this week that he expected "a material drop" in the shots' effectiveness against the new variant.
Lab tests to measure Omicron's vulnerability to the vaccines in use today are under way, a process that should yield results in two to three weeks.
Pfizer, Johnson & Johnson and Moderna each say they have begun work on a new version of their vaccine specifically targeting Omicron -- in case existing jabs don't work against it.
When Delta arrived on the scene, Pfizer developed a jab especially for the variant but never rolled it out.
"Labs ended up relying on the fact that their jabs protected against severe Covid - but it still allows the virus to circulate," said Bruno Canard, a coronavirus expert at French national research institute CNRS.
Pfizer has promised a new vaccine within 100 days but the roll-out will take far longer and won't be in place before spring, Canard said.
"In the meantime, current vaccines protect against serious forms of Covid from the Delta variant."
Related Topics
Recent Stories
Azam Khan likely to miss T20I series against Kiwis due to discomfort in right kn ..
Badar Shahbaz Warraich appointed as PM’s media coordinator
Finance Minister rules out rupee devaluation in talks with IMF
National team determined for good performance against New Zealand: Babar Azam
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 18 April 2024
Today Gold Rate in Pakistan 18 April 2024
Saka and Odegaard start for Arsenal, Guerreiro in Bayern midfield
Qatar PM says re-evaluating Israel-Hamas mediation role
Govt spokesperson terms allegations of PTI's Marwat against Saudi Arabia 'heinou ..
Minister appreciate UAE’s support for Pakistan economic challenges
Manchester City v Real Madrid Champions League starting line-ups
MIGA's support Pakistan in attracting foreign investments: Federal Minister for ..
More Stories From Health
-
World Hemophilia Day observed to underscore importance of providing comprehensive care
17 hours ago -
Six in a family with heart on the 'right side'
17 hours ago -
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
20 hours ago -
World Hemophilia Day observed
22 hours ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
9 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
9 days ago
-
Health activists express concerns over attempts to derail tobacco control
11 days ago -
UHS declares MBBS first prof, MS urology exam results
20 days ago -
Increased diagnostic testing for drug resistance
26 days ago -
IRD releases groundbreaking results of end TB programme
28 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
1 month ago -
JRF to provide insulin to underprivileged diabetic patients
1 month ago